Future Market Insights17h
Global Spinal Cord Stimulators Market Set to Reach USD 5,441.4 Million by 2033, Driven by Technological Innovations and Clinical Advancements | FMI
Spinal Cord Stimulators Market. The global spinal cord stimulators market is on an accelerated growth path, projected to ...
Supernus Pharmaceuticals, Inc.: Supernus Announces FDA Approval of ONAPGO (apomorphine hydrochloride) for Parkinson's Disease
ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson's diseaseONAPGO is a wearable subcutaneous infusion devi ...
manilatimes6h
Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson's Disease
ONAPGO is a prescription medicine used to treat motor fluctuations (OFF episodes) in adults with advanced Parkinson's disease (PD). It is not known if ONAPGO is safe and effective in children. Do not ...